Lexicon Pharmaceuticals
LXRX
#6237
Rank
$1.03 B
Marketcap
$2.32
Share price
-0.81%
Change (1 day)
127.56%
Change (1 year)

EPS for Lexicon Pharmaceuticals (LXRX)

EPS in 2026 (TTM): -$0.07000

According to Lexicon Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -$0.07000. In 2025 the company made an earnings per share (EPS) of -$0.14 an increase over its 2024 EPS that were of -$0.64.

EPS history for Lexicon Pharmaceuticals from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-$0.07000-50%
2025-$0.14-78.13%
2024-$0.64-20%
2023-$0.8031.15%
2022-$0.61-0%
2021-$0.6110.91%
2020-$0.55-145.08%
2019$1.22-206.09%
2018-$1.15-5.74%
2017-$1.22-10.95%
2016-$1.372640%
2015-$0.05000-96.34%
2014-$1.36-2.53%
2013-$1.40-9.09%
2012-$1.54

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Thermo Fisher Scientific
TMO
$18.22-26,128.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
$5.53-8,000.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
$42.53-60,857.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
-$6.11 8,628.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
$7.84-11,300.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
-$0.02000-71.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
-$0.75 971.43%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
$1.40-2,100.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-$1,637 2,338,114.29%๐Ÿ‡บ๐Ÿ‡ธ USA